We compared a regimen of six chemotherapeutic agents administered sequentially at high doses, followed by myeloablative treatment and bone marrow transplantation, with a regimen of methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin (MACOP-B) as initial or salvage treatment for adults with diffuse large-cell lymphoma.
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma / A. M. Gianni, M. Bregni, S. Siena, C. Brambilla, M. Di Nicola, F. Lombardi, L. Gandola, C. Tarella, A. Pileri, F. Ravagnani, P. Valagussa, G. Bonadonna. - In: NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 336:18(1997 May 01), pp. 1290-7-1297.
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma
A. M. Gianni;S. Siena;C. Tarella;
1997
Abstract
We compared a regimen of six chemotherapeutic agents administered sequentially at high doses, followed by myeloablative treatment and bone marrow transplantation, with a regimen of methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin (MACOP-B) as initial or salvage treatment for adults with diffuse large-cell lymphoma.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
